Stay updated on Phase II Pembrolizumab Plus GVD Clinical Trial

Sign up to get notified when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Pembrolizumab Plus GVD Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A consolidated Locations section lists Florida, New Jersey, and New York sites, replacing the previous separate location subsections. The revision tag updates to v3.3.3 and the old state location sections are removed.
    Difference
    0.3%
    Check dated 2025-12-23T17:27:09.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Eligibility criteria now require lab values from before Cycle 1 of Pembrolizumab-GVD. Renal function is assessed by eGFR (≥60 mL/min), replacing prior CrCl/GFR language.
    Difference
    0.3%
    Check dated 2025-12-09T01:11:39.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added and v3.2.0 removed. This update does not affect study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2025-11-24T21:25:51.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the government funding status notice/banner from the page. The study details, including interventions, criteria, and contacts, remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T19:19:04.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page shows minor visual/layout updates and an updated last-updated timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T13:19:48.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Core content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.
    Difference
    2%
    Check dated 2025-10-06T04:15:17.000Z thumbnail image

Stay in the know with updates to Phase II Pembrolizumab Plus GVD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.